Equity incl. NCI
Balance – as of period end · $M
FY2022
−85$M
All values (5)
| Period | Value ($M) | Status |
|---|---|---|
| FY2025 | 1,364 | reported |
| FY2024 | 965 | reported |
| FY2023 | −98 | reported |
| FY2022 | −85 | reported |
| FY2021 | −40 | reported |
| FY2016 – FY2020 | – | missing (5 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: equity_total
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- −$85.0M
- Period
- FY2022, ended Dec 31, 2022 · as of Dec 31, 2022 (balance as of date, not a sum)
- Source
- 10-K, filed Feb 14, 2025 · 0001736297-25-000003
- Location
- us-gaap:StockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | −$85.0M | Feb 14, 2025 | 10-K 0001736297-25-000003 | reported · confidence 1. · current |